DEC 30, 2020 7:30 AM PST

Llama Antibody Prevents Infection by COVID-19

WRITTEN BY: Annie Lennon

There's more to llamas than being livestock and hilarious companion animals. They also harbor an immune system capable of making antibodies that could effectively prevent infection by the coronavirus. 

Over the course of the COVID-19 pandemic, many researchers have scrambled towards llamas for a therapeutic solution. Researchers from the University of Pittsburgh and the University of Texas, for example, have produced antibodies with their llamas that appear to be capable of preventing COVID-19. But why this animal and not another? 

Camelids, a group of animals that includes camels, llamas, and alpacas produce a special type of antibody known as a nanobody. At around a tenth of the weight of human antibodies, they are also more stable and less expensive to produce, yet mimic their tips and arms. And it is these tips that play a crucial role in recognizing proteins on viruses, bacteria, and other antigens. 

While research on these nanobodies is relatively new, they have already been shown as more effective than traditional treatments for thrombotic thrombocytopenic purpura, a rare blood disorder. As such, since the COVID-19 outbreak, researchers have tried to produce a llama nanobody that can act against the SARS-CoV-2 spike protein- the part of the COVID-19 virus that enables it to enter healthy cells via their ACE2 receptors. 

For the present paper, researchers from the National Institutes of Health (NIH) immunized a llama called Cormac five times over 28 days with a purified version of the SARS-CoV-2 spike protein.

In doing so, they found that one of Cormac's nanobodies, now known as NIH-CoVnb-112, was able to bind to ACE2 receptors on healthy cells 2-10 times better than llama nanobodies produced elsewhere. These effects remained even when nanobodies were applied using a nebulizer, the kind of inhaler used by patients with asthma. 

"Although we have a lot more work ahead of us, these results represent a promising first step," says Thomas J. Esparza, lead author of the study.

"With support from the NIH we are quickly moving forward to test whether these nanobodies could be safe and effective preventative treatments for COVID-19. Collaborators are also working to find out whether they could be used for inexpensive and accurate testing."

 

Sources: Neuroscience NewsNature

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
JAN 11, 2021
Cell & Molecular Biology
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
JAN 11, 2021
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
Naturally occurring chemicals make more appealing medicines for many people, but there is not always evidence that they' ...
FEB 25, 2021
Drug Discovery & Development
Future COVID-19 Targets Rapidly Identified with Computer Simulations
FEB 25, 2021
Future COVID-19 Targets Rapidly Identified with Computer Simulations
A recent mechanism as detailed in the novel SARS-CoV2 that causes COVID-19 could help scientists find new therapeutics. ...
APR 06, 2021
Infographics
Psychedelic Medicine 101
APR 06, 2021
Psychedelic Medicine 101
As clinical trials for psychedelics progress, interest in psychedelics is increasing among pharmaceutical firms, clinici ...
MAR 09, 2021
Drug Discovery & Development
Leprosy Drug Repurposed for Potential COVID19 Treatment
MAR 09, 2021
Leprosy Drug Repurposed for Potential COVID19 Treatment
New research published in Nature study shows that a drug for treating leprosy was repurposed to treat COVID19. The study ...
APR 01, 2021
Drug Discovery & Development
Injection Treats Childhood Blindness
APR 01, 2021
Injection Treats Childhood Blindness
A patient with a genetic-based childhood blindness has gained vision after receiving an experimental RNA therapeutic tre ...
Loading Comments...